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Abstract
Molecular and genetic evidence suggests that DNA repair pathways may contribute to lymphoma susceptibility. Several
studies have examined the association of DNA repair genes with lymphoma risk, but the findings from these reports have
been inconsistent. Here we provide the results of a focused analysis of genetic variation in DNA repair genes and their
association with the risk of non-Hodgkin’s lymphoma (NHL). With a population of 1,297 NHL cases and 1,946 controls, we
have performed a two-stage case/control association analysis of 446 single nucleotide polymorphisms (SNPs) tagging the
genetic variation in 81 DNA repair genes. We found the most significant association with NHL risk in the ATM locus for
rs227060 (OR=1.27, 95% CI: 1.13–1.43, p=6.77610
25), which remained significant after adjustment for multiple testing. In a
subtype-specific analysis, associations were also observed for the ATM locus among both diffuse large B-cell lymphomas
(DLBCL) and small lymphocytic lymphomas (SLL), however there was no association observed among follicular lymphomas
(FL). In addition, our study provides suggestive evidence of an interaction between SNPs in MRE11A and NBS1 associated
with NHL risk (OR=0.51, 95% CI: 0.34–0.77, p=0.0002). Finally, an imputation analysis using the 1,000 Genomes Project data
combined with a functional prediction analysis revealed the presence of biologically relevant variants that correlate with the
observed association signals. While the findings generated here warrant independent validation, the results of our large
study suggest that ATM may be a novel locus associated with the risk of multiple subtypes of NHL.
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Introduction
The incidence of non-Hodgkin’s lymphoma (NHL) in the U.S.
has doubled over the past two decades. While the etiology of the
disease remains largely unknown [1], surmounting evidence
suggests that genetic predisposition plays a role in NHL
development [2–4]. Besides recently completed genome-wide
association studies (GWAS) [5–13], the search for missing genetic
susceptibility to lymphoma in the past decade also involved the
association analyses of common genetic variants in candidate
molecular pathways putatively involved in lymphoma develop-
ment. In contrast to GWAS, candidate scans allow for the focused
assessment of biologically relevant molecular pathways by testing
larger sample populations and maintaining a higher statistical
power for detecting association effects [14]. Among the candidate
networks previously investigated for the association with NHL risk,
DNA repair was frequently explored [15–25] due to its strong
relevance to lymphomagenesis [26–28].
Associations between DNA repair genes and lymphoma risk
have been reported previously [15–19], however the results in
many of these studies either failed to reach the necessary level of
statistical significance, or lacked independent validation. In the
present study, we attempted to improve on these prior efforts by
performing a two-stage case-control analysis of 1,297 NHL cases
and 1,946 controls to identify associations between 446 SNPs
tagging 81 DNA repair genes and NHL risk. The two-stage design,
thorough selection of DNA repair genes, assessment of genetic
interactions, and identification of putatively functional variants by
using public genomic and expression data are among the major
innovations in our study, which provides yet another focused
exploration of the role of DNA repair pathways in genetic
susceptibility to NHL.
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Ethics Statement
All cases were ascertained through Memorial Sloan-Kettering
Cancer Center (MSKCC) IRB-approved protocols, or a protocol
approved by the IRB at the Dana Farber Cancer Institute (DFCI)
or Hadassah-Hebrew University. These protocols required written
informed consent either for identified use of specimens for
research into the genetic basis of lymphoma, or research use of
specimens permanently de-identified prior to genotyping. Controls
were part of the New York Cancer Project (NYCP) and all subjects
gave written consent for use of samples in genetic studies of any
disease state.
Study population
In total, the study involved 1,297 non-Hodgkin’s lymphoma
(NHL) cases from the combined resources at MSKCC, DFCI and
Hadassah-Hebrew University, Israel as well as 1,946 controls
collected from the NYCP, a study of 18,000 New York City
residents originally designed to assess the role of environment and
genetics in cancer risk, and described previously elsewhere [29–
31]. The NYCP data include age, gender, history of cancers
(including lymphoma) and ethnicity. A subset of NHL cases
(n=222) were probands from families with a strong family history
(FH) of NHL, described in detail recently [32]. The remaining
fraction of NHL patients (n=1,075), were unrelated and
unselected for FH. All cases and controls were of white European
ancestry, with a fraction of cases (n=534, 41.2%) and controls
(n=1,043, 53.6%) of self reported Ashkenazi Jewish (AJ) ancestry.
In this study we have employed a two-stage design; the discovery
stage (stage 1) consisting of 650 cases and 965 controls, and the
replication stage (stage 2) involving 647 cases and 981 controls.
The detailed structure, demographic, and clinical information of
case/control populations in both stage 1 and 2 is summarized in
Table S1. A subset of the patient collection in this study was
previously included in a GWAS on lymphoma susceptibility [9].
Of the 944 lymphoma cases that constituted the GWAS phase of
that prior study, 515 cases (39.7%) overlap with the 1,297 patients
included here. While 1,043 controls (53.6%) overlap between the
current study and the validation stage of the prior GWAS, there
was no control overlap between this study and the GWAS
discovery stage.
Selection of genes and tagging SNPs (tSNPs)
The selection of candidate DNA repair genes was performed as
summarized in Figure S1. The initial subset of genes (n=34) has
been identified for their known role in DNA repair processes and
queried for their catalytic activities from Gene Ontology (GO) [33]
and KEGG [34]. The key networks of DNA repair defined by the
catalytic domains in the seed list were further passed to: 1) GO
search for genes containing identified catalytic activities and 2)
yeast proteome database [35] identifying yeast homologues with
experimental evidence demonstrating their effect on UV sensitiv-
ity, radiation, and DNA damage response. The yeast genes were
subsequently queried for human homologues. The targets from 1)
and 2) were crossed for gene overlap and passed to an interactome
analysis (GeneGO, Ingenuity) to query interacting partners
(defined by at least two independent reports, and confirmed by
at least two experimental methods). After merging, 87 DNA repair
genes were identified for the study (Table S2). The SNPs tagging
87 selected genes were chosen using Haploview with a haplotype
Pearson’s correlation coefficient (r
2) threshold ,0.6 across selected
gene regions (including 5 kb from 39 and 59 UTR), and minor
allele frequency (MAF) .0.05. The tagging SNP selection has
been performed using the CEU data (120 individuals) of HapMap
Phase II, the most accurate resource available for this purpose at
the time of the study design and still serves as the most validated
reference for capturing the common genetic variation in European
populations. In total, 531 tagging SNPs (tSNPs) were selected to
tag the 87 DNA repair genes.
Genotyping
For stage 1, the genotyping of 531 tSNPs from 87 selected DNA
repair genes on 698 lymphoma cases and 1,041 controls was
conducted using Sequenom MassARRAY iPLEX (Sequenom
Inc., CA), multiplexed into a 16-plex design as per manufacturer’s
protocol and as described previously [30]. For quality control
(QC), duplicates (8 per each 384-well plate) showed .99%
concordance and non-template controls (2 per plate) revealed no
evidence of cross-contamination. Thirty-four SNPs were excluded
due to low genotyping rate across samples (,85%), poor
clustering, or significant departure from Hardy-Weinberg Equi-
librium (p,0.001 in control population); an additional 51 SNPs
were dropped due to low MAF (,0.05) in our study population.
Forty-eight cases and 76 controls were dropped due to low
genotyping rate (,85%). After QC, in total 446 SNPs, tagging 81
DNA repair genes and n=650 cases and n=965 controls
remained for the association analysis in stage 1. Twenty-eight
SNPs associated with NHL (p,0.05) from stage 1 were passed to
the validation analysis in stage 2 on an additional 684 cases and
1,042 controls. In order to perform downstream haplotype and
imputation analyses, in stage 2 we also included 81 additional
SNPs tagging the genes captured by the 28 significant loci in stage
1. A total of 109 SNPs were passed to the replication analysis in
stage 2 using a re-plexed Sequenom design (iPLEX). While all 109
SNPs passed the QC in stage 2, 37 cases and 61 controls were
dropped due to low genotyping rates across SNPs (,85%),
resulting in the genotyping data on 109 SNPs in 647 cases and 981
controls. Data can be made available to other researchers: please
contact the authors for details.
Statistical association analyses
Single SNP associations with NHL risk were tested using a
logistic regression model under a per-allele test, calculating odds
ratios (OR) and 95% confidence intervals (95% CI), adjusted for
age, gender and AJ status. The associations were analyzed for
stage 1, stage 2, and the aggregate sample set including both
stages. In the aggregate sample set we also used a per-allele logistic
regression model to test fifteen SNP associations within the three
most common NHL subtypes in our dataset: diffuse large B-cell
lymphoma (DLBCL), follicular lymphoma (FL) and small
lymphocytic lymphoma/chronic lymphocytic leukemia (SLL/
CLL). Quantile/quantile (Q/Q) plots were produced using ggplot2
in R, and inflation factors (l) were calculated based on 90% of
least significant SNPs. Statistical analyses were performed using
PLINK [36]. The main analysis examining single SNP associa-
tions with NHL risk and the associations among subtypes were
controlled for multiple testing using Bonferroni adjustment. The
Bonferroni level of significance was defined as p,0.000154,
accounting for 247 independent SNPs in stage 1, 33 independent
SNPs in stage 2, and 15 SNPs tested among three NHL subtypes
(number of tests=247+33+(15*3)=325; p=0.05/
325=0.000154). Independent SNPs were defined under Pearson’s
correlation coefficient (r-square) ,0.5 calculated among our
sample population.
Haplotypes were visualized by Haploview and haplotype
associations were performed by logistic regression analysis adjusted
for age, gender, and AJ status. We have also tested the
DNA Repair Pathways and Risk of NHL
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by calculating the Breslow-Day statistics for each SNP.
In order to explore possible epistatic interactions associated with
NHL risk, logistic regressions were modeled by adding an
interaction term between the genotypes of each SNP pair. First,
pairwise comparisons were performed between each SNP from the
list of fifteen associations with NHL (105 tests), followed by
pairwise comparisons of fifteen SNPs with the additional 94 SNPs
included in the aggregate analysis (1,410 tests, Bonferroni adjusted
p-value: 0.05/(105+1410) =3.3610
25). This analysis was per-
formed using PLINK [36]. For the targeted analysis of the MRN
complex (MRE11A, NBS1), the multiplicative two-way gene-gene
interactions were estimated using multiple logistic regression
models. For each SNP pair, a logistic regression model was built
to test case/control association based on the indicator variables
(sex, age and AJ status) and the 2-SNP variable, for a total of 5
variables and an intercept. The 2-SNP variable was defined
separately under three genetic models, based on the number of risk
alleles in individual subjects.
For the assessment of SNP-gene association by incorporating
expression information (expressed quantitative trait loci – eQTL)
we used Genevar [37]. The eQTL associations were calculated by
Spearman’s rank correlation tests.
Imputation and functional prediction
The imputation of genotypes from 1,297 NHL cases and 1,946
controls was performed using IMPUTE2 [38] with a reference
panel consisting of the 1,000 Genomes Project (1KG) data freeze
from November 2010 for low-coverage genomes, May 2011 for
high-coverage exomes, and the phased haplotypes released March
2012 (n=1,092 individuals). Imputed loci were filtered based on
the quality metric score (info score) .0.7 [39], chosen based on
inflation estimates from a Q/Q analysis; the imputed SNPs with
info score ,0.7 showed significant inflations in our data (Figure
S2). The functional annotation of the associated tagging SNPs and
their correlated imputed SNPs was performed by ANNOVAR
[40], focusing on 8 functional categories: coding regions,
conserved transcription factor (TF) binding sites, TF binding sites
based on ChIP-Seq data (using ENCODE database), enhancer
sites based on H3K4me1 chromatin marks (using ENCODE
database), DNase I hypersensitivity clusters (using ENCODE
database), known CNVs, and 39 UTR, and 59 UTR.
Results
Sample population
The demographic and clinical composition of our sample
population is summarized in Table S1. No significant difference
was observed in the distribution of demographic variables or
lymphoma subtypes between stage 1 and stage 2. Also, no
significant difference between demographic characteristics or
subtype distribution has been noted between cases with FH and
NHL cases unselected for FH. However, there was a difference in
the proportion of age, AJ ancestry and gender between the NHL
cases and controls. Hence, age, AJ status and gender were used as
covariates in all subsequent statistical analyses.
Single SNP associations with NHL risk
In this study we applied a two-stage design: in stage 1 we
performed the association analysis on 446 SNPs tagging 81 DNA
repair genes in the population of 650 cases and 965 controls.
There was no significant inflation in observed versus expected
associations (l=1.07), indicating no detectable genotyping arti-
facts or population substructures impacting our findings (Figure
S3).
We first tested the association of DNA repair variants with NHL
cases (all subtypes pooled). The association analysis of NHL cases
in stage 1 identified 28 SNPs associated with NHL risk (p,0.05).
The strongest associations in stage 1 were found for 3 SNPs in the
ATM locus: rs611646, rs419716 and rs227060, the latter showing
the strongest effect (OR=1.27, 95% CI: 1.07–1.49, p=0.005).
Other associations in stage 1 included tSNPs in MRE11A
(rs625245, OR=0.78, 95% CI: 0.65–0.93, p=0.006), GTF2H1
(rs4150606, OR=0.82, 95% CI: 0.69–0.97, p=0.02), and MSH2
(rs4952887, OR=0.66, 95% CI: 0.47–0.91, p=0.01).
The twenty-eight most significant SNPs from stage 1 and an
additional 81 SNPs, as described in Materials and Methods (total
109 SNPs) were passed to stage 2, which involved 647 NHL cases
and 981 controls. The associations were replicated for rs227060
and rs611646 in ATM with a more pronounced effect than in stage
1; rs227060 again shows the strongest association in stage 2
(OR=1.30, 95% CI: 1.10–1.54, p=0.002). Other SNPs that
replicated in stage 2 include GTF2H1 (rs4150606, OR=0.81,
95% CI: 0.68–0.95, p=0.01), MSH2 (rs4952887, OR=0.76, 95%
CI: 0.58–1.01, p=0.05) and MRE11A (rs625245, OR=0.84, 95%
CI: 0.69–1.01, p=0.05). See Table S3 for the complete association
results.
In the aggregate analysis of stage 1 and 2, fifteen SNPs showed
associations with NHL risk (Table 1). These included two SNPs in
the ATM locus: rs227060 and rs611646 (OR=1.27, 95% CI:
1.13–1.43, pagg=0.00007; OR=1.26, 95% CI: 1.12–1.43,
pagg=0.00015, respectively, where pagg is a p-value from
aggregate analysis). Importantly, the associations for both loci
remained significant after Bonferroni correction, as detailed in
Material and Methods (padj =0.022; padj=0.049, respectively,
where padj is the Bonferroni corrected p-value for each SNP). The
two SNPs show incomplete LD (r
2=0.642, Figure S4). In order to
test whether the associations in ATM were independent we
conditioned the analyses by the status of rs227060 and found
rs611646 and rs419716 no longer significant (data not shown),
suggesting the association signals observed for ATM SNPs are
correlated. No other SNP associations in the aggregate analysis
passed Bonferroni correction. To further explore the structure of
associated loci, we also examined common haplotypes (MAF.
0.05) for association with NHL risk. The strongest risk effect has
been observed for a haplotype in ATM. Other loci have also shown
specific haplotypes associated with NHL risk, however none were
more significant than the associations from single SNP analyses
(Table S4). As our study population includes a large fraction of AJ
ancestry, we have investigated potential association differences
between AJ and non-AJ samples. The majority of the 109 SNPs
(n=94) in the aggregate analysis show no more than a 5%
difference in minor allele frequency (MAFs) between AJ and non-
AJ subsets (Figure S5). Three SNPs (rs4150606, rs7149962,
rs7562048) that present with .5% difference in MAF also show
association with NHL. The analysis stratified by AJ status
indicated that most associations, including our two most significant
ATM SNPs, appear to be largely driven by non-AJ subsets which
are predominant in our case population (Table S5). However, for
other SNP associations such as rs4150606 (GTF2H1), rs4952887
(MSH2), and rs702019 (POLQ), both AJ and non-AJ subsets
contribute to the association signal. Therefore, all analyses in the
study were also adjusted by AJ status.
The associations of DNA repair genes with NHL subtypes
We have further tested the associations identified in the NHL
pooled analysis among NHL subtypes on fifteen SNPs that
DNA Repair Pathways and Risk of NHL
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PLOS ONE | www.plosone.org 4 July 2014 | Volume 9 | Issue 7 | e101685associated with overall NHL risk in the aggregate analysis. We
focused on the three most common NHL subtypes in our study
population in order to maintain analytical power: diffuse large B-
cell lymphomas (DLBCL), follicular lymphomas (FL), and small
lymphocytic lymphoma/chronic lymphocytic leukemia (SLL/
CLL). As shown in Table 2, associations were identified for the
three ATM tSNPs in DLBCL (n=412), with the strongest effect for
rs611646 (OR=1.37, 95% CI 1.14–1.64, p=0.0008). Associa-
tions for rs611646 and rs227060 were also observed in SLL/CLL
(n=164). No ATM tSNPs were associated with risk in the FL
subset (n=301). In contrast, the strongest effects in FL was
observed for CHEK1 (rs565416, OR=0.71, 95% CI: 0.58–0.87,
p=0.001) and TDP1 (rs7149962, OR=1.64, 95% CI: 1.14–2.35,
p=0.007), which were not associated with DLBCL or SLL/CLL.
In SLL/CLL, the strongest association effect was found for
rs4150606 tagging GTF2H1 (OR=0.51, 95% CI: 0.39–0.69,
p=4.84610
26); this association was not seen in FL or DLBCL
sub-analyses. The association of rs4150606 with SLL/CLL
remains significant after Bonferroni correction for multiple testing
(padj=0.0016). The SNP/MAF plot between AJ and non-AJ
(Figure S5) identified rs4150606 as an outlier. Despite the MAF
difference it appears that both AJ and non-AJ ancestries contribute
to the observed association risk effect of rs4150606 (Table S5).
We have also tested the association heterogeneity among the
three major subtypes in our analysis of fifteen SNPs (Table 2). The
Breslow-Day test results showed an association for rs227060
(p=0.037), indicating heterogeneity in the odds ratios between the
DLBCL, SLL/CLL, and FL. Heterogeneity has also been
observed for an additional two SNPs with subtype-specific
associations: rs4150606 (GTF2H1, p=0.001) and rs565416
(CHEK1, p=0.006).
The epistatic SNP-SNP interactions in DNA repair genes
and NHL risk
Using the additive model in pairwise SNP-SNP interaction
analysis, we found several associations with NHL risk among the
top fifteen SNPs from the aggregate analysis. However, none of
these associations survived the adjustment for multiple testing
(Table S6). Nonetheless, we noted several interactions of variants
in MRE11A with SNPs in NBS1 associated with NHL risk.
Interestingly, both genes biologically interact in the MRN
complex, a centerpiece of double strand break repair machinery,
which prompted us to examine these interactions more closely
using different genetic models. While all interactions involve
rs1805812 in NBS1, for MRE11A there are four different variants
which contribute to these associations (rs10831227, rs625245,
rs607974, rs557148). After examination of the four pairwise
associations (rs1805812 in NBS1 with each of the four MRE11A
SNPs) using three genetic models (Models 1–3 detailed in Table
S7), we focused on two pairwise interactions with the strongest
effects, rs1805812 (NBS1) x rs625245 (MRE11A) and rs1805812
(NBS1) x rs607974 (MRE11A). As shown in Table 3, the strongest
interaction association was observed for rs1805812 x rs607974
under Model 3, with the strongest effect for heterozygotes or
homozygotes for the minor allele on both gene loci (MRE11A,
NBS1). The association observed for rs1805812 x rs625245 also
shows the strongest effect under Model 3 (Table 4). Interestingly,
both of these interactions replicate independently in both stage 1
and 2.
Imputation and functional predictions using data from
the 1,000 Genomes Project
In order to identify the SNPs with putative functional impact,
we imputed all associated loci from the aggregate analysis using
data from the 1,000 Genomes Project (1KG; described in Material
and Methods). As seen in Figure 1, the association analysis of
imputed data did not yield association effects that were stronger
than those observed in the analysis of genotyped SNPs. The
imputation, however, identified variants that correlate with
genotyped SNPs and show an association effect comparable with
single SNP analyses of aggregate data (Figure 1). To investigate
possible biological implications of these associations we tested the
imputed SNPs using ANNOVAR (Materials and Methods). While
only one non-synonymous SNP was found among the imputed
variants (rs1381057 in POLQ), other imputed SNPs map within
high-impact regulatory regions. In the ATM locus we found
numerous putatively functional variants strongly correlated with
associated tSNPs (Table 5). Of these, rs228594 merits particular
attention; it maps in a DNase I hypersensitivity cluster as well as
within junD and FOSL2 binding sites, providing a rationale for
future molecular exploration. The detailed list of imputed SNPs
with predicted functional impact is in Table S8.
eQTL analysis
Using Genevar [37] we investigated eQTL associations for the
ATM region by examining publicly available data collected from
lymphoblastoid cell lines (LCL), T-cell lines (TCL), and fibroblast
cell lines (FCL) derived from 75 individuals of European ancestry
[41]. Out of the three ATM SNPs associated with NHL risk in our
data, the most significant eQTL effect was observed for rs227060
in LCL based on data from probe ILMN_1716231, showing that
reduced expression correlates with the risk allele (genetic
correlation coefficient rho=0.284, p=0.0136; Figure S6). Inter-
estingly, for the probe ILMN_1716231, the association of
rs227060 with ATM expression was the second most significant
eQTL in the region (Figure 2).
Discussion
Extensive published data suggest that DNA repair pathways are
associated with lymphoma susceptibility [26,27]. The rare
syndromes attributed to inherited mutations in DNA repair genes,
such as ataxia talangiectasia (A-T; mutations in ATM) or Nijmegen
breakage syndrome (NBS; mutations in NBS1) manifest with early
onset lymphomas of various histological subtypes [42,43]. DNA
repair plays a central role in B-cell development in germinal
centers of primary and secondary lymphoid organs via V(D)J
recombination, which is regulated by the genes involved in double
strand break repair, mainly in non-homologous end-joining
(NHEJ) [26]. The mouse knockout models of different components
of NHEJ have serious defects in the V(D)J recombination process
and manifest with increased incidence of B-cell specific lympho-
mas [26,44,45]. Also, inherited immunodeficiency syndromes (e.g.
SCID), which are often associated with early onset lymphomas
[26] are due to germline mutations in NHEJ genes. This and other
evidence points to the importance of DNA repair genes in
lymphomagenesis and suggest that these pathways are putative
candidates in the susceptibility to lymphoma. In this study we
tested common genetic variation in DNA repair genes for its role
in susceptibility to NHL. The two-stage design, the thorough
computational selection of DNA repair targets, the examination of
potential epistatic effects of the associated loci, and the suggested
functional implication of associated variants are among the major
enhancements of our study design compared to prior efforts.
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DNA Repair Pathways and Risk of NHL
PLOS ONE | www.plosone.org 8 July 2014 | Volume 9 | Issue 7 | e101685In this study, we report the most significant association with risk
of NHL for two SNPs in the ATM locus, remaining significant
after adjustment for multiple testing (Bonferroni). Although among
FL patients there was no association observed, ATM SNPs did
correlate with risk of DLBCL and SLL/CLL. While the FL subset
was the second largest in the study (n=301), many other subtypes
were underrepresented (n,100) and hence it was not possible to
assess risk among these smaller groups due to the limited power
(although a suggestive, yet non-significant effect was observed
among Mantle Cell lymphomas; rs611646, OR=1.45, 95% CI:
1.03–2.05, p=0.035). It is also important to note that the
associations of ATM SNPs are stronger among the pooled NHL
analysis (all subtypes) compared to separate associations with
DLBCL or SLL/CLL. This evidence suggests for the first time
that ATM is a putatively novel candidate NHL susceptibility locus.
In our study we have noted association differences in stratified
analyses by AJ status (Table S5). This relates to the two most
significant ATM SNPs, which show the significant risk effect only
in non-AJ population. While the frequency of the risk allele of both
SNPs appears to be similar among AJ and non-AJ cases (for
rs227060 MAF=40%, for rs611646 MAF=48%), the MAF in AJ
and non-AJ controls differs by approximately 4% (for rs227060
MAF=37% and 33% respectively, for rs611646 MAF=45% and
MAF=42% respectively). While there is a possibility of underlying
genetic substructure [46,47], we believe reduced power of the AJ
stratified sub-analysis is the most plausible explanation for the
observed differences in the risk effects between AJ and non-AJ
subsets, as AJ cases are underrepresented by ,43% compared to
non-AJ cases in the study. It is likely that despite the differences in
allele frequency of both SNPs in AJ, the risk would be detected by
increasing the number of cases to a comparable size of the non-AJ
subset. The issue of power reduction contributing to the observed
association differences between AJ and non-AJ is further supported
by the same directionality of odds ratios in both AJ and non-AJ
subsets and aggregate analysis. To explore both possibilities in
detail, a larger validation analysis and possibly the detailed fine
mapping of the ATM locus in AJ as well as non AJ populations will
be needed.
Prior evidence linking ATM with lymphoid malignancies has
been largely restricted to the somatic level; ATM somatic
mutations were noted in particular lymphoma subtypes of DLBCL
[48], CLL [49–52], and MCL [53,54], consistent with the results
of the subtype-specific analysis in our data. Rare germline variants
in ATM (MAF,0.05) have previously been associated with CLL
susceptibility [25], however as the current study focused on
common variants (MAF.0.05), these SNPs are not strongly
correlated with tSNPs in our study (r
2,0.1). The study by
Sipahimalani, et al. performed an extensive analysis exploring the
association of six common genetic variants in ATM with
lymphoma risk [55]. Notably, while the least significant ATM
SNP associated with NHL risk in our data, rs419716, is strongly
correlated with one of the SNPs from that prior study, rs664982
(r
2.0.9), no association was reported for rs664982 by Sipahima-
lani, et al. [55], although the directionality of the effects for both
SNPs is similar. The smaller sample size (798 cases, 793 controls)
of this prior report, together with a more heterogeneous
population (.15% of Asian ancestry) likely explains the different
association outcomes [55]. The different distribution of NHL
subtypes in the study by Sipahimalani, et al. provides another
possible explanation. While our strongest signals appear to be
driven by associations of ATM SNPs in DLBCL and SLL/CLL,
the study population from Sipahimalani, et al. had a much higher
proportion of FL, for which we did not observe an association in
our study. DLBCL specific GWAS studies have been previously
Figure 1. The results of association analysis, displayed as Manhattan plot, after imputation of 28 SNPs genotyped in both stage 1
and 2, which tag 11 DNA repair genes that showed association with NHL risk in our study. The SNPs and genes are ordered by
chromosomal position (x-axis). The associations are displayed as –log10(p-value) for each SNP. Red dots represent fifteen tagging SNPs that were
genotyped in our study and were associated with NHL risk. Green dots represent tagging SNPs that were genotyped in our study and that showed no
association with NHL. Blue markers represent SNPs imputed by IMPUTE from 1KG. The red dotted line defines the threshold of p-value ,0.05. *
indicates an associated SNP with a putatively functional impact; non-synonymous coding change or SNP mapping in: transcription factor binding site,
H3K4Me1 chromatin mark, DNaseI hypersensitivity cluster, 59UTR, 39UTR.
doi:10.1371/journal.pone.0101685.g001
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DNA Repair Pathways and Risk of NHL
PLOS ONE | www.plosone.org 10 July 2014 | Volume 9 | Issue 7 | e101685reported [7,12], and most recently a large GWAS by international
consortia has identified novel loci in apoptotic pathways associated
with the risk of SLL/CLL [11]. While ATM was not among the
reported associations in these prior studies, these reports focused
only on the loci that passed the threshold of genome wide level of
significance. For independent confirmation, a separate deeper
analysis of this published data will be needed in the follow up study
to validate the potential association effect of ATM with SLL/CLL
and DLBCL in the large populations studied in these scans.
Although the replication of our findings in NHL subtypes will be
critical as part of the prior and upcoming GWAS studies from
large consortia, it will also be very important to test the association
effect of identified ATM variants in pooled NHL population,
where we observed the most significant associations in our
analysis. Such rationale is particularly relevant given the critical
role of DNA repair pathways (with ATM as an important cell cycle
checkpoint) in early development of progenitor B and T-cell
lineages [56–59] via the process of V(D)J recombination producing
diverse immune repertoire [60]. Because of the common origin of
these precursor cell populations among different NHL subtypes, it
is reasonable to hypothesize that variation in DNA repair networks
in these progenitor cells could confer risk effects that are shared
among multiple NHL subtypes, as we have suggested in our most
recent GWAS scan [9] and as also discussed previously [7].
Additionally, double-stranded DNA break and non-homologous
end joining repair mechanisms have been implicated in the
occurrence of chromothripsis [61], which has recently been
observed in both CLL and DLBCL [62–64] and proposed along
with ‘‘chromoplexy’’ [65] to be involved in a punctuated cancer
evolution. ATM is a critical checkpoint impacting both homolo-
gous recombination and non-homologous end joining [66]. It is
possible that the inherited genetic variants in ATM may affect the
capacity of DSB repair in a way that would associate with the
patterns of specific large-scale genomic alterations and rearrange-
ments in a subset of cells in the tumor due to yet unknown genetic
or microenvironment modifiers. Although in the context of this
study it is highly speculative, given the associations with the ATM
locus observed here, such a biological scenario is an attractive
possibility and should be further investigated in detail on the
somatic level of lymphomagenesis.
Numerous other studies have previously examined the germline
variation in major DNA repair genes for their association with
lymphoma risk [15–17,19]. However, mostly due to the limited
selection of candidates, limited power or lack of independent
validation, the results were of marginal significance. These
borderline associations included the variants in nucleotide excision
repair proteins, such as XRCC1 and XRCC2 [17], cell cycle protein
BLM [19], and MGMT, a gene involved in DNA repair of
alkylation damage [17]. We examined those previously associated
loci, which had perfect proxies in our data and observed a
borderline association in stage 1 for a proxy of rs1799782 in
XRCC1 [17], (rs3213344, OR=1.44, 95% CI: 1.03–2.01,
p=0.03), however this SNP did not replicate in our stage 2.
MRE11A and NBS1, which were associated with NHL risk in our
study, were examined in a previous report on a small subset of
NHL population [18]. Although some marginal associations with
NHL risk were observed, the SNPs reported in that previous study
were in weak correlation with the variants in MRE11A and NBS1
associated with lymphoma risk in our analysis.
One novelty of our study design compared to prior efforts is the
exploratory assessment of potential epistatic effects in DNA repair
networks contributing to lymphoma risk. Our data suggest that the
interactions between several genetic variants in MRE11A and
NBS1, critical components of the MRN complex, associate with
Figure 2. The distribution of eQTLs across the region of ATM determined by ILMN_1716231 probe from the data of lymphoblastoid
cell lines from 75 individuals of European ancestry. The eQTLs were identified using Genevar. The eQTL association with rs227060 (arrow), the
most significant SNP associated with NHL risk in our data, is the second strongest eQTL across ATM locus. The circles indicate all SNPs that correlate
with rs227060. Zoom in shows eQTL associations of four correlated SNPs in lymphoblastoid cell line versus T-cell and fibroblastoid cell lines. The eQTL
associations are displayed as –log10(p-value) on y-axis.
doi:10.1371/journal.pone.0101685.g002
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PLOS ONE | www.plosone.org 11 July 2014 | Volume 9 | Issue 7 | e101685increased risk of NHL. Interestingly, these findings show that the
carriers of at least one copy of the minor (protective) allele
inherited in both MRE11A and NBS1 are at more than a 2-fold
reduced risk of developing NHL compared to the single SNP effect
of each locus separately. While these findings are novel they are
also exploratory, given the reduced power of this analysis and the
fact that none of these observations reached the significance
threshold adjusted for multiple testing. Importantly however, these
epistatic interactions were observed in both stage 1 and 2
separately (Table 3 and Table 4) suggesting that the observed
SNP-SNP associations merit further attention. Looking forward,
the addition of other critical checkpoint DNA repair genes (such as
ATM or CHEK1/2) to the MRN interaction model found in our
study would be of interest. This analysis, along with the
independent validation of epistatic and single SNP associations
identified here, will need to be performed in a large consortium as
part of the analyses following up on recent reports [11,67].
Our study provides a suggestive link between the associated
SNPs and putatively functional variants to be pursued in
subsequent molecular studies. By imputing our data from the
public resources of 1KG we have identified several functional
variants highly correlated with the SNPs associated with NHL risk
in our study. Most notably, several of the variants in ATM were
located within multiple functional regions, as annotated utilizing
ENCODE data from lymphoblastoid cell lines. For example,
rs228594, rs228599, and rs189037, which correlate with the
associations observed in ATM, map within known transcription
factor binding sites as well as chromatin marks, DNase I
hypersensitivity clusters, and 59 UTR, strongly supporting a
possible impact on expression regulation.
The eQTL association with our top SNP, rs227060, was the
second most significant eQTL association within the ATM region,
and was detected in lymphoblastoid cell lines but not in fibroblast
controls [41] (Figure 2). The observed eQTL effect shows the
reduced expression of ATM correlating with the dosage of
rs227060 risk allele. The reduction of ATM expression has been
strongly linked with radiosensitivity and defective DNA damage-
induced ATM-dependent signaling in various experimental studies,
and was clearly shown to promote the tumor growth in lymphoma
and other cancer models [68]. However, despite the potential
biological implications of these associations, more detailed
molecular investigations will be needed to link the imputed loci
with lymphomageneis. Nonetheless, the in-silico functional predic-
tions as presented here can substantially improve subsequent fine
mapping strategies of associated SNPs. At the same time this
approach can reduce the need for a large scale re-sequencing by
functional prioritizing the target variants for further molecular
investigation.
Besides ATM, other loci also showed association effects in
pooled NHL or subtype-specific analyses. As power limitations of
our study may also be a concern, subsequent validation of these
findings should be performed in large consortia. These future
studies, with the concomitant collection of epidemiologic data and
clinical characteristics, will also allow for a more in-depth analysis
of potential gene-environment interactions attributed to DNA
repair pathways. At the same time, the utilization of data from
completed and ongoing lymphoma GWAS will be critical for the
assessment of other interacting molecular pathways that may
define the complex genetic susceptibility to NHL. For example,
the HLA locus has been consistently replicated as a low-penetrant
allele in recent NHL GWAS and follow-up meta-analyses
[7,8,10,11,32,69]. It has been shown that the innate immunity
pathways are closely connected with particular DNA repair
networks (e.g. B-cell maturation in germinal centers) [58,70],
suggesting that detailed exploration of such interactions will be
important. Our results strongly support the strategies for the
pathway analysis of data from current and future GWAS on
lymphoma susceptibility, using a deep validation of associations,
considering the loci that did not reach genome-wide association
thresholds, but may be biologically related. Our observations
indicate that the genetic variants in key biological pathways, such
as DNA repair, may account for an additional fraction of missing
inherited susceptibility to lymphoid neoplasia. The associations
observed here can also serve as the basis for further molecular
investigations of the biological roles of the implicated loci on both
a germline and somatic level. Such investigations will contribute
not only to more efficient risk algorithms, but will lead to the
improved understanding of lymphomagenesis for more effective
targeting of therapy and prevention.
Supporting Information
Figure S1 Strategy schema for the selection of candi-
date DNA repair genes in the study.
(TIF)
Figure S2 Quantile/Quantile (Q/Q) plot comparing –
log10(expected p-value) vs. –log10(observed p-value)
under different quality metric scores (info). Based on
imputation analysis of 109 genotyped SNPs using IMPUTE2. Q/
Q analysis of imputed data was used to select quality score
threshold with least inflation of significant SNPs, which we have
set at 0.7.
(TIF)
Figure S3 Quantile/Quantile (Q/Q) plot of the associ-
ation results from stage 1 SNPs genotyped in 650 NHL
cases and 965 controls; 2log10(expected p-value) vs.
2log10(observed p-value). The blue dashded line indicates the
inflation factor based on 90% of the least significant SNPs
(l=1.07).
(TIF)
Figure S4 LD structure generated by Haploview shown
for ATM gene region. The triangle plot displays correlation
between the three tagging SNPs genotyped in the study (r
2 values).
The associations of individual SNPs are displayed as 2log10(p-
value) for each SNP from the main effect aggregate analysis.
(TIF)
Figure S5 Minor allele frequency plot for non-AJ vs. AJ
samples. Data based on allele frequencies in the aggregate
analysis (for 109 SNPs with genotype information in stage 1 and
stage 2). Blue dots indicate those SNPs associated with NHL in the
aggregate analysis. Only 15 SNPs (14%) showed a difference in
MAF .0.05. Indicated by arrows are NHL associated SNPs which
did show a MAF difference .0.05 between non-AJ and AJ
samples.
(TIF)
Figure S6 Genotype vs. expression (eQTL) results for
rs227060 and four expression probes across the ATM
locus. Data generated from lymphoblastoid cell lines (GenCord-
L), T-cell lines (GenCord-T) and fibroblastoid cell lines (GenCord-
F) established from 5 individuals of European ancestry. The most
significant association for rs227060 in GenCord-L has been
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PLOS ONE | www.plosone.org 12 July 2014 | Volume 9 | Issue 7 | e101685observed for ILMN-1716231. Data were generated using
Genevar.
(TIF)
Table S1 Summary of the demographic characteristics
of the case/control study population.
(XLSX)
Table S2 List of DNA repair genes and tagging SNPs
genotyped. Chromosome and base pair position are based on
GRCh37/hg19 build. Allele frequencies calculated among our
sample population.
(XLSX)
Table S3 Results of single SNP associations analysis of
tSNPs in DNA repair genes with the risk of NHL
observed in our study, including 109 SNPs genotyped
in stage 1 and stage 2.
(XLSX)
Table S4 Full list of haplotype associations (p,0.05) for
DNA repair genes associated with NHL in our study.
(XLSX)
Table S5 Stratified AJ and non-AJ results for SNPs
associated with NHL in the main effect aggregate
analysis.
(XLSX)
Table S6 Results from pairwise SNP-SNP interaction
associations of tSNPs in DNA repair genes with NHL
risk. A) Pairwise comparisons among the 15 tSNPs associated
with NHL risk in the aggregate main effect analysis. B) Pairwise
comparisons of 15 tSNPs with all additional SNPs genotyped in
both stage 1 and stage 2 (n=94). Associations between MRE11A
and NBS1 are shaded in grey.
(XLSX)
Table S7 Pairwise interaction results between NBS1
(rs1805812) and MRE11A (rs607974, rs625245, rs557148,
rs10831227) and NHL risk under three different genetic
models. Each model was tested for a different SNP x SNP
combination between rs1805812 and 4 SNPs tagging MRE11A.
Indicated are the different combinations of genotypes used for
each respective genetic model.
(XLSX)
Table S8 Summary of tagging and imputed SNPs in
DNA repair genes associated with NHL risk with high
predicted functional impact. Functional information was
annotated using ANNOVAR, and included data generated from
the ENCODE project.
(XLSX)
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